Transcriptional Regulation of Angiotensinogen Gene Expression

Vitamins and Hormones

Volumn 57, Issue C, 1997, Pages 217-247

  Brasier, Allan R ^a   Han, Youqi ^a   Sherman, Christopher T ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN;

ANIMAL; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; NUCLEOTIDE SEQUENCE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

ANGIOTENSINOGEN; ANIMALS; BASE SEQUENCE; GENE EXPRESSION REGULATION; HUMANS; RENIN-ANGIOTENSIN SYSTEM; TRANSCRIPTION, GENETIC;

EID: 0032601983     PISSN: 00836729     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0083-6729(08)60645-7     Document Type: Article

References (110)

1. Baeuerle P.A. The inducible transcription activator NF-kappa B: Regulation by distinct protein subunits. Biochim. Biophys. Acta 1072 (1991) 63-80
2. Beato M. Gene regulation by steroid hormones. Cell 56 (1989) 335-344
3. Beato M. Chromatin structure and the regulation of gene expression: Remodeling at the MMTV promoter. J. Mol. Med. 7 (1996) 711-724
4. Beg A.A., and Baldwin A.S.J. The I kappa B proteins: Multifunctional regulators of Rel/NF-kappa B transcription factors. Genes Dev. 7 (1993) 2064-2070
5. Beutler B., Krochin K., Milsonk I.W., Leudke C., and Cerami A. Control of cachectin (TNF) synthesis: Mechanism of endotoxin resistance. Science 232 (1986) 977-980
6. Birch H., and Schreiber G. Transcriptional regulation of plasma protein synthesis during inflammation. J. Biol. Chem. 261 (1986) 8077-8080
7. Bouhnik J., Cassio D., Coezy E., Corvol P., and Weiss M. Angiotensinogen production by rat hepatoma cells in culture and analysis of its regulation by techniques of somatic cell genetics. J. Cell Biology 97 (1983) 549-555
8. Bouhnik J., Savoie F., and Corvol P. Differential effects of inflammation models on rat T-kininogen and rat angiotensinogen. Biochem. Pharmacol. 37 (1988) 1099-1102
9. Bouscarel B., Blackmore P.F., and Exton J.H. Characterization of the angiotensin II receptor in primary cultures of rat hepatocytes. J. Biol. Chem. 263 (1988) 14913-14919
10. Brasier A.R., and Kumar A. Identification of a novel determinant for basic domain-leucine zipper (bZIP) DNA-binding activity in the acute-phase inducible nuclear factor-interleukin 6 transcription factor. J. Biol. Chem. 269 (1994) 10341-10351
11. Brasier A.R., and Li J. Mechanisms for inducible control of angiotensinogen gene transcription. J. Hypertens. 27 (1996) 465-475
12. Brasier A.R., Li J., and Wimbish K.A. Tumor necrosis factor activates angiotensinogen gene expression by the Rel A transactivator. J. Hypertens. 27 (1996) 1009-1017
13. Brasier A.R., Philippe J., Campbell D.J., and Habener J.F. Novel expression of the angiotensinogen gene in a rat pancreatic islet cell line: Transcriptional regulation by glucocorticoids. J. Biol. Chem. 261 (1986) 16148-16154
14. Brasier A.R., Tate J.E., Ron D., and Habener J.F. Multiple cis-acting DNA regulatory elements mediate hepatic angiotensinogen gene expression. Mol. Endocrinol. 3 (1989) 1022-1034
15. Brasier A.R., Ron D., Tate J.E., and Habener J.F. Synergistic enhansons located within an acute phase responsive enhancer modulate glucocorticoid induction of angiotensinogen gene transcription. Mol. Endocrinol. 4 (1990) 1921-1933
16. Brasier A.R., Ron D., Tate J.E., and Habener J.F. A family of constitutive C/EBP-like DNA binding proteins attenuate the IL-1 alpha induced. NF kappa B mediated trans-activation of the angiotensinogen gene acute-phase response element. EMBO J. 9 (1990) 3933-3944
17. Brown K., Gerstberger S., Carlson L., Franzoso G., and Siebenlist U. Control of IκB-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 267 (1995) 1485-1488
18. Campbell D.J. Circulating and tissue angiotensin systems. J. Clin. Invest. 79 (1987) 1-6
19. Campbell D.J., and Habener J.F. Angiotensinogen gene is expressed and differentially regulated in multiple tissues of the rat. J. Clin. Invest. 78 (1986) 31-39
20. Campbell D.J., and Habener J.F. Cellular localization of angiotensinogen gene expression in brown adipose tissue and mesentery: Quantification of messenger ribonucleic acid abundance using hybridization. In situ. Endocrinology 121 (1988) 1616-1626
21. Cassio D., Weiss M.C., Ott M.-O., Sala-Trepat J.M., Fries J., and Erdos T. Expression of the albumin gene in rat hepatoma cells and their dedifferentiated variants. Cell 27 (1981) 351-358
22. Cassis L.A., Saye J., and Peach M.J. Localization and regulation of rat angiotensinogen messenger RNA. Hypertension 11 (1988) 591-596
23. Caulfield M., Lavender P., Farrall M., Munroe P., Lawson M., Turner P., and Clark A.J. Linkage of the angiotensinogen gene to essential hypertension. N. Engl. J. Med. 330 (1994) 1629-1633
24. Chang E., and Perlman A.J. Angiotensinogen mRNA. Regulation by cell cycle and growth factors. J. Biol. Chem. 263 (1988) 5480-5484
25. Clouston W.M., Evans L.A., Haralambidis J., and Richards R.I. Molecular cloning of the mouse angiotensinogen gene. Genomics 2 (1988) 240-248
26. Clouston W.M., Lyons I.G., and Richards R.I. Tissue-specific and hormonal regulation of angiotensinogen minigenes in transgenic mice. EMBO J. 8 (1989) 3337-3343
27. Coezy E., Bouhnik J., Clauser E., Pinet F., Philippe M., Menard J., and Corvol P. Effects of glucocorticoids and antiglucocorticoids on angiotensinogen production by hepatoma cells in culture. In Vitro 20 (1984) 528-534
28. Corvol P., and Jeunemaitre X. Molecular genetics of human hypertension: Role of angiotensinogen. Endoc. Rev. 18 (1977) 662-677
29. Derkx F.H., Steunkel C., Schalekamp M.P., Visser W., Huisveld I.H., and Schalekamp M.A. Immunoreactive renin, prorenin, and enzymatically active renin in plasma during pregnancy and in women taking oral contraceptives. J. Clin. Endocrinol. Metab. 63 (1986) 1008-1015
30. DiDonato J., Mercurio F., Rosette C., Wu-Li J., Suyang H., Ghosh S., and Karin M. Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol. 16 (1996) 1295-1304
31. DiDonato J.A., Hayakawa M., Rothwarf D.M., Zandl E., and Karin M. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388 (1997) 548-554
32. Doolittle R.F. Angiotensinogen is related to the antitrypsin-antithrombin-ovalbumin family. Science 222 (1983) 417-419
33. Ducher L., Croquet F., Gil S., Davy J., Feger J., and Brehier A. Differential expression of five protein kinase C isoenzymes in FAO and HepG2 hepatoma cell lines compared with normal rat hepatocytes. Biochem. Biophys. Res. Commun. 217 (1995) 546-553
34. Dynan W.S., and Tjian R. The promoter-specific transcription factor SP-1 binds to upstream sequences in the SV40 early promoter. Cell 35 (1983) 79-87
35. Eggena P., Zhu J.H., Clegg K., and Barrett J.D. Nuclear angiotensin receptors induce transcription of renin and angiotensinogen mRNA. Hypertension 22 (1993) 496-501
36. Ellison K.E., Ingelfinger J.R., Pivor M., and Dzau V. Androgen regulation of rat renal angiotensinogen messenger RNA expression. J. Clin. Invest. 83 (1989) 1941-1945
37. Freedman L.P., Luisi B.F., Korszun Z.R., Basavappa R., Sigler P.B., and Yamamoto K.R. The function and structure of the metal coordination sites within the glucocorticoid receptor DNA binding domain. Nature 334 (1988) 543-546
38. Fukamizu A., Sugimura K., Takimoto E., Sugiyama F., Seo M.S., Takahashi S., Hatae T., Kajiwara N., Yagami K., and Murakami K. Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes. J. Biol. Chem. 268 (1993) 11617-11621
39. Fukamizu A., Takahashi S., Seo M.S., Tada M., Tanimoto K., Uehara S., and Murakami K. Structure and expression of the human angiotensinogen gene. J. Biol. Chem. 265 (1990) 7576-7582
40. Gaillard I., Clauser E., and Corvol P. Structure of human angiotensinogen gene. DNA 8 (1989) 87-99
41. Gordon M.S., Chin W.W., and Shupnik M.A. Regulation of angiotensinogen gene expression by estrogen. J. Hypertens. 10 (1992) 361-366
42. Han Y., and Brasier A.R. Mechanism for biphasic Rel A:NF-κB1 nuclear translocation in tumor necrosis factor α-stimulated hepatocytes. J. Biol. Chem. 272 (1997) 9823-9830
43. Haskill S., Beg A.A., Tompkins S.M., Morris J.S., Yurochko Sampson A.D., Johannes A., Mondal K., Ralph P., and Baldwin Jr. A.S. Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity. Cell 65 (1991) 1281-1289
44. Henkel T., Machleidt T., Alkalay I., Kronke M., Ben-Neriah Y., and Baeuerle P.A. Rapid proteolysis of I kappa B-alpha is necessary for activation of transcription factor NF-kappa B. Nature 365 (1993) 182-185
45. Hilgenfeldt U., and Schwind S. Angiotensin II is the mediator of the increase in hepatic angiotensinogen synthesis after bilateral nephrectomy. Am. J. Physiol. 265 (1993) E414-E418
46. HojNielsen A., and Knudsen F. Angiotensinogen is an acute-phase protein in man. Scand. J. Clin. Lab. Invest. 47 (1987) 175-178
47. Hopkins P.N., Lipton R.P., Hollenberg S.M., Jeunemaitre X., Hallouin M.-C., Skuppin J., Williams C.S., Dluhy R.G., Lalouel J.M., Williams R.R., and Williams G.H. Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. J. Hyperten. 14 (1996) 199-207
48. Ingelfinger J.R., Zuo W.M., Fon E.A., Ellison K.E., and Dzau V.J. In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. An hypothesis for the intrarenal renin angiotensin system. J. Clin. Invest. 85 (1990) 417-423
49. Inoue I., Nakajima T., Williams C.S., Quackenbush J., Puryear R., Powers M., Cheng T., Ludwig W.H., Sharma A.M., Harta A., Jeunemaitre X., and Lalouel J.M. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J. Clin. Invest. 99 (1997) 1786-1797
50. Inoue J., Kerr L.D., Kakizuka A., and Verma I.M. IκB-γ, a 70kD protein identical to the C-terminal half of p110 NF-κB: A new member of the IκB family. Cell 68 (1992) 1109-1120
51. Jantzen H.M., Strahle U., Gloss B., Stewart F., Schmid W., Boshart M., Miksicek R., and Schutz G. Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene. Cell 49 (1987) 29-38
52. Jeunemaitre X., Soubrier F., Kotelevtsev Y.V., Lifton R.P., Williams C.S., Charru A., Hunt S.C., Hopkins P.N., Williams R.R., and Lalouel J.M. Molecular basis of human hypertension: Role of angiotensinogen. Cell 71 (1992) 169-180
53. Jeunemaitre X., Inoue I., Williams C., Charru A., Tichet J., Powers M., Sharma A.M., Roqueplo G.-A.-P., and Corvol P. Haplotypes of angiotensinogen in essential hypertension. Am. J. Hum. Genet. 51 (1997) 1448-1460
54. Jones K.D., Yamamoto K.R., and Tjian R. Two distinct transcription factors bind to the HSV promoter in vitro. Cell 42 (1985) 559-572
55. Kageyama R., Ohkubo H., and Nakanishi S. Induction of rat liver angiotensinogen mRNA following acute inflammation. Biochem. Biophys. Res. Commun. 129 (1985) 826-832
56. Kalinyak J.E., and Perlman A.J. Tissue-specific regulation of angiotensinogen mRNA accumulation by dexamethasone. J. Biol. Chem. 262 (1987) 460-464
57. Kerr L.D., Inoue J., Davis N., Link E., Baeuerle P.A., Bose Jr. H.R., and Verma I.M. The rel-associated pp40 protein prevents DNA binding of Rel and NF-kappa B: Relationship with I kappa B beta and regulation by phosphorylation. Genes Dev. 5 (1991) 1464-1476
58. Kim H.S., Krege J.H., Kluckman K.D., Hagaman J.R., Hodgin J.B., Best C.F., Jennette J.C., Coffman T.M., Maeda N., and Smithies O. Genetic control of blood pressure and the angiotensinogen locus. Proc. Natl. Acad. Sci. USA 92 (1995) 2735-2739
59. Klett C., and Hackenthal E. Induction of angiotensinogen synthesis and secretion by angiotensin II. Clin. Exp. Hypertens. 49 (1987) 2027-2047
60. Klett C., Nobiling R., Gierschik P., and Hackenthal E. Angiotensin II stimulates the synthesis of angiotensinogen in hepatocytes by inhibiting adenylylcyclase activity and stabilizing angiotensinogen mRNA. J. Biol. Chem. 268 (1993) 25095-25107
61. Klett C., Hellmann W., Hackenthal E., and Ganten D. Modulation of tissue angiotensinogen gene expression by glucocorticoids, estrogens, and androgens in SHR and WKY rats. Clin. Exp. Hypertens. 15 (1993) 683-708
62. Kohara K., Brosnihan K.B., Ferrario C.M., and Milsted A. Peripheral and central angiotensin II regulates expression of genes of the renin-angiotensin system. Am. J. Physiol. 262 (1992) E651-E657
63. Krakoff L.R. Measurement of plasma-renin substrate by radioimmunoassay of angiotensin. I. Concentration in syndromes associated with steroid excess. J. Clin. Endocrinol. Metab. 37 (1973) 110-117
64. Kunsch C., Ruben S.M., and Rosen C.A. Selection of optimal κ/Rel DNA-binding motifs: Interaction of both subunits of NF-κB with DNA is required for transcriptional activation. Mol. Cell. Biol. 12 (1992) 4412-4421
65. Li J., and Brasier A.R. Angiotensinogen gene activation by angiotensin II is mediated by the rel A (nuclear factor -κB p65) transcription factor. One mechanism for the renin angiotensin system positive feedback loop in hepatocytes. Mol. Endocrinol. 10 (1996) 252-264
66. Lyle R.E., Habener J.F., and McGehee Jr. R.E. Antisense oligonucleotides to differentiation-specific element binding protein (DSEB) mRNA inhibit adipocyte differentiation. Biochem. Biophys. Res. Commun. 228 (1996) 709-715
67. McGehee Jr. R.E., and Habener J.F. Differentiation-specific element binding protein (DSEB) binds to a defined element in the promoter of the angiotensinogen gene required for the irreversible induction of gene expression during differentiation of 3T3-L1 adipoblasts to adipocytes. Mol. Endocrinol. 9 (1995) 487-501
68. McGehee Jr. R.E., Ron D., Brasier A.R., and Habener J.F. Differentiation-specific element: A cis-acting developmental switch required for the sustained transcriptional expression of the angiotensinogen gene during hormonal-induced differentiation of 3T3-L1 fibroblasts to adipocytes. Mol. Endocrinol. 7 (1993) 551-560
69. Mercurio F., DiDonato J.A., Rosette C., and Karin M. p105 and p98 precursor proteins play an active role in NF-κB-mediated signal transduction. Genes Dev. 7 (1993) 705-718
70. Morgan T., Craven C., Nelson L., Lalouel J.M., and Ward K. Angiotensinogen T235 expression is elevated in decidual spiral arteries. J. Clin. Invest. 100 (1997) 1406-1415
71. Morishita R., Higaki J., Okunishi H., Tanaka T., Ishii K., Nagano M., Mikami H., Ogihara T., Murakami K., and Miyazaki M. Changes in gene expression of the renin-angiotensin system in two kidney, one clip hypertensive rats. J. Hypertens. 9 (1991) 187-192
72. Morishita R., Higaki J., Tomita N., Aoki M., Moriguchi A., Tamura K., Murakami K., Kaneda Y., and Ogihara T. Role of transcriptional cis-elements, angiotensinogen gene-activating elements, of angiotensinogen gene in blood pressure regulation. Hypertension 27 (1996) 502-507
73. Murphy T.J., Alexander R.W., Griendling K.K., Runge M.S., and Bernstein K.E. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 351 (1991) 233-236
74. Naftilan A., Zuo W., Ingelfinger J.R., Ryan T.J., Pratt R.E., and Dzau V. Localization and differential regulation of angiotensinogen mRNA expression in the vascular wall. J. Clin. Invest. 87 (1991) 1300-1311
75. Nakamura A., Iwao H., Fukui K., Kimura S., Tamaki T., Nakanishi S., and Abe Y. Regulation of liver angiotensinogen and kidney renin mRNA levels by angiotensin II. Am. J. Physiol. 258 (1990) E1-E6
76. Nibu Y., Takahashi S., Tanimoto K., Murakami K., and Fukamizu A. Identification of cell type-dependent enhancer core element located in the 3′-downstream region of the human angiotensinogen gene. J. Biol. Chem. 269 (1994) 28598-28605
77. Ohkubo H., Nakayama K., Tanaka T., and Nakanishi S. Tissue distribution of rat angiotensinogen mRNA and structural analysis of its heterogeneity. J. Biol. Chem. 261 (1986) 319-323
78. Okamoto H., Hatta A., Itoh N., Ohashi Y., Arakawa K., and Nakanishi S. Acute phase responses of plasma angiotensinogen and T-kininogen in rats. Biochem. Pharmacol. 36 (1987) 3069-3073
79. Orphanides G., Lagrange T., and Reinberg D. The general transcription factors of RNA polymerase II. Genes Dev. 10 (1996) 2657-2683
80. Peach M.J. Renin-angiotensin system: Biochemistry and mechanisms of action. Physiol. Rev. 57 (1977) 313-370
81. Perkins N.D., Schmid R.M., Duckett C.S., Leung K., Rice N.R., and Nabel G.J. Distinct combinations of NF-kappa B subunits determine the specificity of transcriptional activation. Proc. Natl. Acad. Sci. UDA 89 (1992) 1529-1533
82. Racz K., Pinet F., Gasc J.-M., Guyene T.-T., and Corvol P. Coexpression of renin, angiotensinogen, and their messenger ribonucleic acids in adrenal tissues. J. Clin. Endocrinol. Metab. 75 (1992) 730-737
83. Regnier C.H., Song H., Gao X., Goeddel D.V., Cao Z., and Rothe M. Identification and characterization of an IκB kinase. Cell 90 (1997) 373-383
84. Reid I.A., Morris B.J., and Ganong W.G. The renin-angiotensin system. Annu. Rev. Physiol. 40 (1978) 377-410
85. Rice N.R., and Ernst M.K. In vivo control of NF-κB activation by IκB-α. EMBO J. 12 (1993) 4685-4695
86. Rice N.R., MacKichan M.L., and Israel A. The precursor of NF-kappa B p50 has I kappa B-like functions. Cell 71 (1992) 243-253
87. Rigaud G., Roux J., Pictet R., and Grange T. In vivo footprinting of rat TAT gene: Dynamic interplay between the glucocorticoid receptor and a liver specific factor. Cell 67 (1991) 977-986
88. Ron D., Brasier A.R., Wright K.A., and Habener J.F. The permissive role of glucocorticoids on interleukin-1 stimulation of angiotensinogen gene transcription is mediated by an interaction between inducible enhancers. Mol. Cell. Biol. 10 (1990) 4389-4395
89. Ron D., Brasier A.R., Wright K.A., Tate J.E., and Habener J.F. An inducible 50-kilodalton NF kappa B-like protein and a constitutive protein both bind the acute-phase response element of the angiotensinogen gene. Mol. Cell. Biol. 10 (1990) 1023-1032
90. Ruben S.M., Narayanan R., Klement J.F., Chen C.H., and Rosen C.A. Functional characterization of the NF-kappa B p65 transcriptional activator and an alternatively spliced derivative. Mol. Cell. Biol. 12 (1992) 444-454
91. Ryan M., Shen P.J., and Gundlach A.L. Angiotensinogen and natriuretic peptide mRNAs in rat brain: Localization and differential regulation by adrenal steroids in hypothalamus. Peptides 18 (1997) 495-504
92. Sato N., Katsuya T., Rakugi H., Takami S., Nakata Y., Miki T., Higata J., and Ogihara T. Association of variants in critical core promoter element of angiotensinogen gene with increased risk of essential hypertension in Japanese. Hypertension 30 (1997) 321-325
93. Schmid R.M., Perkins N.D., Duckett C.S., Andrews P.C., and Nabel G.J. Cloning of an NF-kappa B subunit which stimulates HIV transcription in synergy with p65. Nature 352 (1991) 733-736
94. Schmitz M.L., and Baeuerle P.A. The p65 subunit is responsible for the strong transcription activating potential of NF-κB. EMBO J. 12 (1991) 3805-3817
95. Sernia C. Location and secretion of brain angiotensinogen. Regul. Pept. 57 (1995) 1-18
96. Shade R.E., Davis J.O., Johnson J.A., Gotshall R.W., and Spielman W.S. Mechanism of action of angiotensin II and antidiuretic hormone on renin secretion. Am. J. Physiol. 224 (1979) 926-943
97. Siebenlist U., Franzoso G., and Brown K. Structure, regulation and function of NF-κB. Annu. Rev. Cell Biol. 10 (1994) 405-455
98. Skinner S.L., Lumbers E.R., and Symonds E.M. Analysis of changes in the renin-angiotensin system during pregnancy. Clin. Sci. 42 (1972) 479-488
99. Sun S.C., Ganchi P.A., Ballard D.W., and Greene W.C. NF-kappa B controls expression of inhibitor I kappa B alpha: Evidence for an inducible autoregulatory pathway. Science 259 (1993) 1912-1915
100. Tamura K., Umemura S., Ishii M., Tanimoto K., Murakami K., and Fukamizu A. Molecular mechanism of transcriptional activation of angiotensinogen gene by proximal promoter. J. Clin. Invest. 93 (1994) 1370-1379
101. Tanaka T., Ohkubo H., and Nakanishi S. Common structural organization of the angiotensinogen and the alpha-1 antitrypsin genes. J. Biol. Chem. 259 (1984) 8063-8065
102. Tewksbury D.A. Angiotensinogen: Biochemistry and molecular biology. In: Laragh J.H., and Brenner B.M. (Eds). "Hypertension: Pathophysiology, Diagnosis and Management" (1990), Raven Press, New York 1197-1216
103. Thompson J.E., Phillips R.J., Erdjument-Bromage H., Tempst P., and Ghosh S. IκB-β regulates the persistent response in a biphasic activation of NF-κB. Cell 80 (1995) 573-582
104. Tigerstedt R., and Bergman P. Niere and Kreislauf. Scand. Arch. Physiol. 8 (1898) 223-271
105. Traenckner E.B., Pahl M.H.L., Henkel T., Schmidt K.N., Wilk S., and Baeuerle P.A. Phosphorylation of human IκB-α on serines 32 and 36 controls IκB-α proteolysis and NF-κB activation in response to diverse stimuli. EMBO J. 14 (1995) 2876-2882
106. Walker W.G., Whelton P.K., Saito H., Russel R.P., and Hermann J. Relation between blood pressure and renin, renin substrate, AII, aldosterone and urinary sodium and potassium in 574 ambulatory subjects. Hypertension 1 (1979) 287-291
107. Ward K., Hata A., Jeunemaitre X., Helin L., Nelson C., Namikawa C., Farrington P.F., Ogasawera M., Suzumori K., and Tomoda S. A molecular variant of angiotensinogen associated with preeclampsia. Nat. Gen. 4 (1998) 59-61
108. Yanai K., Nibu Y., Murakami K., and Fukamizu A. A cis-acting DNA element located between TATA box and transcription initiation site is critical in response to regulatory sequences in human angiotensinogen gene. J. Biol. Chem. 271 (1996) 15981-15986
109. Yanai K., Matsuyama S., Murakami K., and Fukamizu A. Differential action of AGCF2 upon cell type-dependent expression of human angiotensinogen gene. FEBS Lett. 412 (1997) 285-289
110. Yanai K., Murakami K., and Fukamizu A. ATF-like element contributes to hepatic activation of human angiotensinogen promoter. Biochem. Biophys. Res. Commun. 237 (1997) 158-162